ORTHOPEDIATRICS CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $236.3 | $204.7 | $148.7 | $122.3 | $98.0 |
| Operating income | -$39.2 | -$35.0 | -$26.8 | -$25.4 | -$18.0 |
| Net income | -$39.6 | -$37.8 | -$21.0 | $1.3 | -$16.3 |
| Cash Flow Statement | |||||
| Free cash flow | -$16.0 | -$41.3 | -$43.9 | -$31.8 | -$21.2 |
Shares outstanding 26.1M · Free float 76.2%
Annual filing data through FY ended December 31, 2025; float as of September 29, 2026.